YAKUGAKU ZASSHI
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 18,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Ken-ichi Hosoya
Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama 
Read more
16,955 registered articles
(updated on November 20, 2018)
Online ISSN : 1347-5231
Print ISSN : 0031-6903
0.293
2017 IMPACT FACTOR
JOURNALS PEER REVIEWED FREE ACCESS ADVANCE PUBLICATION
Featured article
Volume 138 (2018) Issue 11 Pages 1425-1433
Comparison of Adhesive Properties of Transdermal Patches Distributing in Japan—Tack and Peel Strength— Read more
Editor’s picks

Adhesive properties of 38 transdermal patches of ten different active pharmaceutical ingredients (APIs) were measured using unified methods.  The adhesive properties were quite different among the patches, even for the same API, dose, and size.  In the case of generic products for which the bioequivalence to a brand-name product is assured, the variation in the adhesive properties can extend the range of choices for patients.  This study will help medical experts to notice the differences in adhesive properties of transdermal patches.

View the past featured articles
View all articles in Current issue
Most viewed articles Oct.2018
Share this page
Select past volume & issue
feedback
Top